Single Source for Continuation of the Integrated Islet Distribution Program U24 (Clinical Trial Not Allowed)

Summary

This is a single-source (sole-source) federal grant/cooperative agreement opportunity issued by the NIH National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) for continuation of the Integrated Islet Distribution Program (IIDP). The IIDP supports the distribution of human pancreatic islets for research purposes. As a U24 cooperative agreement mechanism, it funds resource centers providing research support and shared resources. Clinical trials are explicitly excluded from this award.

What they want

How they evaluate

Risks & flags

• Explicitly designated as 'Single Source' — non-competitive continuation, meaning only the current incumbent is eligible to apply
• Ultra-narrow eligibility (single source) strongly indicates this opportunity is wired for the existing IIDP awardee
• No competitive review implied; RFA number (RFA-DK-27-147) follows NIH single-source continuation convention
• Short description with minimal scope detail is consistent with pro-forma sole-source justification notices